Angiotensin Receptor Blockers Are Associated with Reduced Fibrosis and Interleukin-6 Expression in Calcific Aortic Valve Disease
Authors:
Open Access
- 21 August 2013
- journal article
- research article
- Published by S. Karger AG in Pathobiology
- Vol. 81 (1) , 15-24
Abstract
Background: Calcific aortic valve disease (CAVD) is a chronic disorder characterized by the mineralization of the aortic valve and involving fibrosis. Objectives: In this work we sought to determine if the fibrotic component of the remodeling process of CAVD was related to the use of angiotensin-converting enzyme inhibitors (ACEi) and/or angiotensin receptor blockers (ARBs). Methods: In 477 patients with CAVD, the aortic valve was examined by histology. A semiquantitative score of fibrosis was generated and associations with clinical/cardiometabolic variables examined. In a subset of 103 patients the aortic valve was available to study the infiltration by inflammatory cells and expression of interleukin-6 (IL-6) by quantitative real-time PCR. Results: The fibrosis score of the aortic valve was independently related to the hemodynamic severity of CAVD measured by echocardiography. The fibrotic score of the aortic valve was also related to the expression of IL-6. The use of ARBs but not of ACEi was associated with a lower fibrosis score of the aortic valve even after correction for covariates. In addition, patients under ARBs had lower aortic valve inflammation and expression of IL-6. Conclusions: These findings suggest that ARBs may alter the fibrotic process of the aortic valve in CAVD, possibly by lowering tissue inflammation.Keywords
This publication has 23 references indexed in Scilit:
- Macrophage-Stimulated Cardiac Fibroblast Production of IL-6 Is Essential for TGF β/Smad Activation and Cardiac Fibrosis Induced by Angiotensin IIPLOS ONE, 2012
- Interleukin 6 Underlies Angiotensin II–Induced Hypertension and Chronic Renal DamageHypertension, 2012
- Calcific Aortic Valve Disease: Not Simply a Degenerative ProcessCirculation, 2011
- Refining Molecular Pathways Leading to Calcific Aortic Valve Stenosis by Studying Gene Expression Profile of Normal and Calcified Stenotic Human Aortic ValvesCirculation: Cardiovascular Genetics, 2009
- Visceral ObesityHypertension, 2009
- Letters to the editorCanadian Journal of Cardiology, 2008
- Angiotensin Receptor-1 Blocker Inhibits Atherosclerotic Changes and Endothelial Disruption of the Aortic Valve in Hypercholesterolemic RabbitsJACC, 2007
- Induction of local angiotensin II-producing systems in stenotic aortic valvesJACC, 2004
- Association of Angiotensin-Converting Enzyme With Low-Density Lipoprotein in Aortic Valvular Lesions and in Human PlasmaCirculation, 2002
- Clinical Factors Associated With Calcific Aortic Valve DiseaseJACC, 1997